Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.

If you liked this article you might like

Medicinal Marijuana Company Doubles Revenue But Struggles to Break Even

Beware of Getting High on Marijuana Stocks

Cannabis College or Bust: TheStreet Goes to Pot School

Jim Cramer on What's in the Pipeline for Pot at TheStreet

Advanced Cannabis Investors Eye Early Harvest